HOME >> MEDICINE >> NEWS
GlaxoSmithKline Drug Discovery and Development Award 2002

In recognition of the need for pioneers to produce new alternatives and hope against the HIV/AIDS pandemic,GlaxoSmithKline (GSK) is offering $500,000 in unrestricted awards for innovative HIV/AIDS drug research.

Applications are now being solicited for 2002 awards and must be submitted by July 31. The one-time awards are from $25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection as well as prophylactic vaccines or microbicides designed to prevent transmission of the virus.

Award recipients will be chosen by three leading independent AIDS researchers. For detailed information about the GSK Drug Discovery and Development Award, as well as an application, please call 1-888-527-6935.

"Science and medicine have made incredible advances in the treatment of people living with HIV in the last decade, and providing support to researchers is key to keeping things moving forward," said Doug Manion, M.D., vice president of clinical development for GSK. "We are supportive of researchers in the scientific community in their ceaseless goal of finding new solutions to drug-resistance and viral mutation, the spread of the virus and simplification of treatment, and who are working towards the eradication of HIV and AIDS."

The award carries no obligation to the recipient's organization for licensure, patenting or transfer of confidential information, although GSK may discuss the possibility of future collaboration with some applicants.

An Expert Review Board comprised of acknowledged leaders in the field of HIV/AIDS will independently judge and choose the award recipients. Although GSK will be able to review proposals, it will not be involved in the selection of recipients.

For purposes of the award program, the judges will define "drug discovery and development" as one or more of the following:

  • The developme
    '"/>


Contact: Elaine Ackert
eackert@pcipr.com
312-558-1770
Public Communications Inc.
14-May-2002


Page: 1 2 3

Related medicine news :

1. TB Alliance announces new drug discovery program with GlaxoSmithKline
2. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
3. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
4. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003
6. GlaxoSmithKline Drug Discovery and Development Award 2002
7. Discovery of pathway in learning impairment caused by liver disease may lead to drug treatment
8. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
9. Discovery of the oldest remains of a woman who died in childbirth
10. Discovery sheds light on how cancer cells grow and divide
11. Discovery changes ideas about damage from strokes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Ocean ... face masks to medical first responders across the United States. Since the start ... personal protective equipment (PPE) medical centers , hospitals , firefighters ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... to dental groups in the United States, today announced the grand opening of ... CA. , Patients will enjoy convenient hours, a comfortable office, and full-service ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/28/2020)... ... 2020 , ... WHAT , Hespiro™ is a new type ... including COVID-19, while reducing the need for scarce mechanical ventilators. It not only ... scrubs it free of carbon dioxide in a completely closed “rebreather” system, important ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... advising Adventist Health on its investment in Synchronous Health, a tech-enabled behavioral health ... combines the strength of human empathy with artificial intelligence (AI) to increase access ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... BETHESDA, Md. (PRWEB) , ... September 02, 2020 , ... ... Dr. Jonathan Lee . Dr. Lee will work at Bethesda Dermatopathology ... graduated with his B.A. from the University of California, Berkley. He went on to ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... Breast and ... of Disease Control (CDC), About 3% of breast cancers (about 7,500 women per year) ... in the BRCA1 and BRCA2 genes. Both genes are detectable in the Women’s ...
(Date:8/31/2020)... ... 2020 , ... Cloudticity announced today that Network Products Guide, ... in the 15th Annual 2020 Network PG’s IT World Awards®. , The IT ... Products Guide honoring achievements of world’s best in organizational performance, product and service ...
Breaking Medicine Technology:
Cached News: